☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Mirati Therapeutics
Mirati Therapeutics’ Krazati (adagrasib) Receives EC’s Approval for Advanced Non-Small Cell Lung Cancer (NSCLC)
January 11, 2024
PharmaShots Weekly Snapshots (October 09–13, 2023) _
October 14, 2023
Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advance...
August 13, 2020
Load more...
Back to Home